Moderna plans to invest about $500 million to build a factory in Africa to make up to 500 million doses of mRNA vaccines each year, it said on Thursday.

In the latest move by the pharmaceuticals industry to manufacture drugs on the continent, Moderna’s proposed site will also include bottling and packaging capabilities. The vaccines will use Moderna’s mRNA technology, but the statement did not say if it would be the U.S. company’s COVID-19 shot.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)